Practical Insights into R&D Project Initiation and Industrialization of Solid Dosage Forms
Lunan Pharmaceutical
Comprehensive Pharmaceutical Group
Amidst the grand wave of the pharmaceutical industry’s advancement toward “Industry 4.0” and intelligent manufacturing, the innovation of production models for solid dosage forms—one of the most widely used and classic dosage forms—has become pivotal to the overall transformation and upgrading of the industry. Currently, the sector is confronting multiple challenges, including stringent cost controls driven by the normalization of volume-based procurement and increasingly rigorous global quality regulatory systems.
In this context, from September 4 to 5, 2026, the 8th CMC-CHINA China Pharmaceutical Industry Expo (Pharma Expo) will concurrently host “SolidFormulation Conference”。
The Forum has specially invitedMr. Hao Guizhou, Director of the Research Department, Lunan Pharmaceutical Group Corporation, sharing the title of"Practical Insights into the Research and Development Project Initiation and Industrialization of Solid Dosage Forms"Frontier Report.
Doctoral Supervisor, Qingdao University; Master’s Supervisor, Ocean University of China.
Recipient of special government allowances from the national and provincial governments, the National May 1st Labor Medal, Taishan Industry Innovation Leading Talent, Qilu Craftsman, Outstanding Engineer Youth Award, Shandong Province Excellent Scientific and Technological Worker, Shandong Province Middle-aged and Young Expert with Outstanding Contributions, and the Fumin Xinglu Labor Medal.
Obtained over 120 production approval documents, led or participated in more than 30 national, provincial, and municipal research projects, filed over 130 invention patent applications, with 90 patents granted.
Recipient of two National Science and Technology Progress Awards, one China Patent Gold Award, four Shandong Provincial Science and Technology Progress Awards, the Person Award of the Invention Entrepreneurship Award from the China Association of Inventions, and the First Prize of the Shandong Provincial Invention Entrepreneurship Award.
01. Forum Information
Organizer:Pharmaceutical Integration Circle
Event Duration:September 4, 2026
Event Location:Suzhou International Expo Center
02. Proposed Topics
Outlook on Opportunities in the Solid Dosage Form Industry at the Start of the “15th Five-Year Plan”
Strategies for Cost Reduction and Efficiency Improvement in Solid Dosage Form Manufacturing Enterprises under the New Normal of Volume-Based Procurement
Compliance Pathways and Case Analysis of Continuous Manufacturing Processes Under the ICH Q13 Guideline
Requirements and Impacts of the Implementation of the 2025 Edition of the Chinese Pharmacopoeia on the Manufacturing Process and Quality Control of Solid Dosage Forms
Regulatory Advances and Review Considerations for Continuous Manufacturing Technologies of Solid Dosage Forms
Dual Control Strategies for Product Quality and Cost in Solid Dosage Form Manufacturers under the New Centralized Procurement Regulations
International Registration Strategy and Case Studies for Solid Dosage Forms under the 505(b)(2) Pathway
Current Status and Implementation Challenges of Continuous Manufacturing Technology in the Field of Solid Dosage Forms
AI-Based Intelligent Optimization of Process Parameters and Defect Prediction for Solid Dosage Forms
Breakthroughs in Solubilization Technologies for Poorly Water-Soluble Drugs: Industrial Applications of Solid Dispersions, Nanocrystals, and Other Technologies
From Laboratory to Factory: Challenges and Strategies for Process Scale-up of Solid Dosage Forms
New Advances in Formulation Design and Process Research for Novel Dosage Forms of Solid Preparations
Breakthroughs in Moisture-Proof Technology for Oral Solid Dosage Forms: Synergistic Protection from Packaging Materials to Formulation Design
Core Points for Controlling Granule Hardness and Uniformity and Solutions to Common Problems in the Scale-Up of Dry Granulation Processes
Implementation of Data Integrity (ALCOA+ Principles) in Solid Dosage Form Production Equipment and Systems
Lecture Consultation: Mr./Ms. Bao 16657151608 (WeChat ID same as phone number)
03. Conference Registration
Registration:
ConferenceLimited-Time Free Access(Limited spots available; registration is on a first-come, first-served basis. This is a pre-registration; successful registration is confirmed upon approval of your application.) Accommodation and meals are at your own expense.
Registration Inquiry:
Mr. Bao 16657151608 (WeChat ID same as phone number)
Ms. Wen 18868801402 (WeChat ID same as phone number)
04. Business Cooperation
Business Cooperation:
Ms. Wang 13588474548 (WeChat ID same as phone number)
Ms. Zhou 15858667450 (WeChat ID same as phone number)
Ms. Zhang 15005862516 (WeChat ID same as phone number)
Ms. Zhou 13983785571 (WeChat ID same as phone number)
05. Review of Previous Editions
